Replies to post #111915 on Amarantus Bioscience Holdings Inc (AMBS)

[brharris]

Already done as noted in the 8k issued yesterday:

On February 23, 2015, the Company filed an IND with the U.S. Food and Drug Administration for its Phase 2b clinical trial for Eltoprazine to treat Levodopa-Induced Dyskinesia in patients with Parkinson’s Disease.